Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Daniela Matuozzo, Estelle Talouarn, Astrid Marchal, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Recent advances and evolving concepts in Still’s disease
Piero Ruscitti, Luca Cantarini, Peter A. Nigrović, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 2, pp. 116-132
Closed Access | Times Cited: 24
Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia
Ana García‐García, Rebeca Pérez de Diego, Carlos Flores, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 5
Open Access | Times Cited: 34
COVID-19 annual update: a narrative review
Michela Biancolella, Vito Luigi Colona, Lucio Luzzatto, et al.
Human Genomics (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 28
The Microbe, the Infection Enigma, and the Host
Jean‐Laurent Casanova, Laurent Abel
Annual Review of Microbiology (2024) Vol. 78, Iss. 1, pp. 103-124
Closed Access | Times Cited: 8
Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology
Man Wang, Fei Yu, Wenguang Chang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Potential associations of selected polymorphic genetic variants with COVID-19 disease susceptibility and severity
Orsolya Mózner, Edit Szabó, Anna Kulin, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316396-e0316396
Open Access
Genetic diversity of the immunoglobulin heavy chain locus in cohorts of patients affected with SARS-CoV-2
Patrizia Malaspina, Carla Jodice, Bianca Maria Ciminelli, et al.
Human Genomics (2025) Vol. 19, Iss. 1
Open Access
Proteomic Analyses in COVID-19-Associated Secondary Hemophagocytic Lymphohistiocytosis
Susan Canny, Ian B. Stanaway, Sarah E. Holton, et al.
Critical Care Explorations (2025) Vol. 7, Iss. 2, pp. e1203-e1203
Open Access
Genetic and Epigenetic Intersections in COVID-19-Associated Cardiovascular Disease: Emerging Insights and Future Directions
Hussein Sabit, Borros Arneth, Afaf Altrawy, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 485-485
Open Access
No Association Between HLH-associated Gene Variants and Life-Threatening COVID-19
Laura Covill, Aurélie Cobat, Qian Zhang, et al.
Journal of Clinical Immunology (2025) Vol. 45, Iss. 1
Open Access
Human determinants of age-dependent patterns of death from infection
Laurent Abel, Jean‐Laurent Casanova
Immunity (2024) Vol. 57, Iss. 7, pp. 1457-1465
Open Access | Times Cited: 4
Inherited and acquired errors of type I interferon immunity govern susceptibility to COVID-19 and multisystem inflammatory syndrome in children
Giorgia Bucciol, Isabelle Meyts, Laurent Abel, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 151, Iss. 4, pp. 832-840
Open Access | Times Cited: 11
Human Genomics of COVID-19 Pneumonia: Contributions of Rare and Common Variants
Aurélie Cobat, Qian Zhang, Laurent Abel, et al.
Annual Review of Biomedical Data Science (2023) Vol. 6, Iss. 1, pp. 465-486
Open Access | Times Cited: 10
Impaired balance between neutrophil extracellular trap formation and degradation by DNases in COVID-19 disease
Geoffrey Garcia, Sylvie Labrouche-Colomer, Alexandre Duvignaud, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Yin and yang of interferons: lessons from the coronavirus disease 2019 (COVID-19) pandemic
Sara Svensson Akusjärvi, Ivan Zanoni
Current Opinion in Immunology (2024) Vol. 87, pp. 102423-102423
Closed Access | Times Cited: 3
Stratified analyses refine association between TLR7 rare variants and severe COVID-19
Jannik Boos, Caspar I. van der Made, Gayatri Ramakrishnan, et al.
Human Genetics and Genomics Advances (2024) Vol. 5, Iss. 4, pp. 100323-100323
Open Access | Times Cited: 3
Identification of biomarkers for COVID-19 associated secondary hemophagocytic lymphohistiocytosis
Susan Canny, Ian B. Stanaway, Sarah E. Holton, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
The inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replication
Paul J. Baker, Andrea C. Bohrer, Ehydel Castro, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Host genetic variants associated with COVID-19 reconsidered in a Slovak cohort
Mária Škereňová, Michal Cibulka, Zuzana Daňková, et al.
Advances in Medical Sciences (2024) Vol. 69, Iss. 1, pp. 198-207
Closed Access | Times Cited: 2
Suppression of Type I Interferon Signaling in Myeloid Cells by Autoantibodies in Severe COVID-19 Patients
Ami Aoki, Chiaki Iwamura, Masahiro Kiuchi, et al.
Journal of Clinical Immunology (2024) Vol. 44, Iss. 4
Open Access | Times Cited: 2
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection
Astrid Marchal, Elizabeth T. Cirulli, Iva Neveux, et al.
Human Genetics and Genomics Advances (2024) Vol. 5, Iss. 3, pp. 100300-100300
Open Access | Times Cited: 2
Rare host variants in ciliary expressed genes contribute to COVID-19 severity in Bulgarian patients
Kunka Kamenarova, Darina Kachakova, Magdalena Baymakova, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review
Gianmarco Bellucci, Angela Albanese, Caterina Rizzi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Role of autoantibodies targeting interferon type 1 in COVID-19 severity: A systematic review and meta-analysis
Abolfazl Akbari, Alireza Hadizadeh, Mahdi Amiri, et al.
Journal of Translational Autoimmunity (2023) Vol. 7, pp. 100219-100219
Open Access | Times Cited: 7
High Anti-Interferon-Alpha Autoantibody Levels in Severe/Critical COVID-19 Patients from Peru
María J. Pons, Ana Mayanga-Herrera, Luciano A. Palomino-Kobayashi, et al.
Journal of Interferon & Cytokine Research (2023) Vol. 43, Iss. 12, pp. 565-570
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top